ASHLEY BIVEN: Open Payments
NPI 1598501389 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,616 in 111 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $52 · 2025 $1,616
Food & beverage: $1,616
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $233 |
| PFIZER INC. | 12 | $183 |
| ABBVIE INC. | 18 | $182 |
| Novo Nordisk Inc | 14 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $132 |
| Lilly USA, LLC | 8 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $76 |
| GlaxoSmithKline, LLC. | 4 | $58 |
| Corcept Therapeutics | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 4 | $53 |
Products named: CAPLYTA, Kerendia, NURTEC ODT, VRAYLAR, MOUNJARO, Wegovy, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
